Ads
related to: stages of cirrhosis of the liver- Why Fatty Liver Matters
Learn More About Nonalcoholic
Fatty Liver Disease Today.
- What Is NASH?
Explore Information About NASH
And See How NASH Progresses.
- How To Test For NASH
Get Details On Noninvasive Tests
& Find The Right Doctor.
- Support Resources
Living With NASH Can Be Difficult.
Get Support Today.
- Sign Up For Updates
Stay Informed On The Latest
NASH News And Information.
- Talking To Your Doctor
See Questions To Ask Your Doctor.
Get The Answers You Need About NASH
- Why Fatty Liver Matters
Search results
Infected Blood Scandal: What are the symptoms and treatments for the deadly virus hepatitis?
The Independent via Yahoo News· 4 days agoBut most people infected as children develop a long-term infection. This is known as chronic...
Beijing drug manufacturer aiming to develop liver fibrosis drug
China Daily· 14 hours agoGyre Pharmaceuticals Co Ltd, also known as Beijing Continent, a Beijing-based innovative drug...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoSAN DIEGO, May 19, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Akero Therapeutics, Inc. (NASDAQ: AKRO) common stock between September
Gilead (GILD) Announces Positive Interim Results on PBC Drug
Zacks via Yahoo Finance· 4 days agoGilead Sciences (GILD) experimental candidate, seladelpar, demonstrates significant improvements in...
Intercept Presents New Data Demonstrating the Impact of OCA-Bezafibrate Combination Therapy on ALP...
Benzinga· 6 days agoResults from a Phase 2 study show combination of OCA 5-10mg and bezafibrate 400mg induced the greatest percent change from baseline in ALP at Month 6 OCA and bezafibrate combination therapy has acceptable
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and...
Morningstar· 6 days agoInvestigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis - 70% of Patients Receiving Seladelpar 10mg Achieved the Clinically Meaningful Composite Endpoint and 37
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors...
WTRF Wheeling· 5 days agoThe law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern ...
Galectin Therapeutics (NASDAQ:GALT) Upgraded to “Hold” by StockNews.com
ETF DAILY NEWS· 3 days agoGalectin Therapeutics (NASDAQ:GALT – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Tuesday. Separately, HC ...
Arbutus to Present Imdusiran Data at EASL Congress 2024 - Arbutus Biopharma (NASDAQ:ABUS)
Benzinga· 2 days agoArbutus Biopharma Corporation ABUS ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional ...
Pittsburgh CLO's 'Lady Day' is a beautiful, raw evening spent with a legend
Pittsburgh Tribune-Review· 2 days agoBillie Holiday will undoubtedly — and deservedly — be a household name for generations to come....
